Skip to main content

Cervicogenic Headache

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

SPR Therapeutics
SPR TherapeuticsOH - Cleveland
1 program
SPRINT Peripheral Nerve StimulationN/A1 trial
Active Trials
NCT05491915Active Not Recruiting50Est. Aug 2027

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
SPR TherapeuticsSPRINT Peripheral Nerve Stimulation

Clinical Trials (1)

Total enrollment: 50 patients across 1 trials

NCT05491915SPR TherapeuticsSPRINT Peripheral Nerve Stimulation

The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain

Start: Oct 2022Est. completion: Aug 202750 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.